K

KMS Medisurgi Limited

KMSMEDI
Market snapshot · 2026-08-11 00:23 UTC

132.80

₹0.00 (+0.00%)

MARKET CAP

₹43.82 Cr

STOCK P/E

179.5x

52W HIGH

₹132.80

52W LOW

₹126.50

BOOK VALUE

₹24.98

EPS

₹0.74

ROE

2.99%

SECTOR

Health Care

DEBT/EQUITY

9.30

VOLUME

2,000

P/B RATIO

5.32x

PEG RATIO

Sector

Health Care

Themes

Health Care Equipment & Supplies
D
Dividend
₹132.80₹131.21₹129.63₹128.04₹126.45VolumeDAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 6.3% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.51). Confidence: 95%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

128.40

Current

179.46

Overvalued

170.95

Undervalued

168.78

EV/EBITDA
Strongly Overvalued

5Y Average

34.96

Current

48.86

Overvalued

45.97

Undervalued

14.49

P/S
Strongly Overvalued

5Y Average

2.57

Current

3.59

Overvalued

3.38

Undervalued

1.06

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Free cash flow

₹-0.21 CrMar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-4.00 Cr0.00 Cr4.00 Cr8.00 Cr12 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Income statement data not available.

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +74.42%74.42%74.42%74.42%74.42%
Public +25.57%25.57%25.57%25.57%25.57%
Others0.01%0.01%0.01%0.01%0.01%
Jun 2026
Promoters +
Public +
Others

Events Timeline

Non-Applicability Of Report On Corporate Governance

Jul 21, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 14, 2026PDFCompany Reports Open

Board Meeting Outcome for Submission Of Standalone Audited Financial Results For The Year Ended 31 March, 2026

May 30, 2026PDFCompany Reports Open

Submission Of Standalone Audited Financial Results For The Year Ended 31 March, 2026

May 30, 2026PDFCompany Reports Open

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On May 30, 2026

May 25, 2026PDFCompany Reports Open